Low-dose butorphanol alleviates remifetanil-induced hyperalgesia in patients undergoing laparoscopic cholecystectomy

Glass, 1993, Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B), Anesth Analg, 77, 1031, 10.1213/00000539-199311000-00028 Rivosecchi, 2014, An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia, Exper Opin Durg Saf, 13, 587, 10.1517/14740338.2014.902931 Chu, 2012, Modulation of remifentanil-induced postinfusion hyperalgesia by the β-blocker propranolol in humans, Pain, 153, 974, 10.1016/j.pain.2012.01.014 Kieffer, 1995, Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides, Cell Mol Neurobiol, 15, 615, 10.1007/BF02071128 Aguado, 2013, Effects of naloxone on opioid-induced hyperalgesia and tolerance to remifentanil under sevoflurane anesthesia in rats, Anesthesiology, 118, 1160, 10.1097/ALN.0b013e3182887526 Tuerke, 2011, Dissociable effects of ultra low-dose naltrexone on tolerance to the antinociceptive and cataleptic effects of morphine, Behav Pharmacol, 22, 558, 10.1097/FBP.0b013e3283474a56 McNaull, 2007, Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists, Eur J Pharmacol, 560, 132, 10.1016/j.ejphar.2006.12.013 Pan, 1998, Mu-opposing actions of the kappa-opioid receptor, Trends Pharmacol Sci, 19, 94, 10.1016/S0165-6147(98)01169-9 Jaw, 1993, Opioid antagonists and butorphanol dependence, Pharmacol Biochem Behav, 44, 497, 10.1016/0091-3057(93)90158-P Gunter, 2000, Continuous epidural butorphanol relieves pruritus associated with epidural morphine infusions in children, Paediatr Anaesth, 10, 167, 10.1046/j.1460-9592.2000.00447.x Wu, 2012, Intravenous butorphanol administration reduces intrathecal morphine-induced pruritus after cesarean delivery: a randomized, double-blinded, placebo-controlled study, J Anesth, 26, 752, 10.1007/s00540-012-1421-7 Wu, 2014, Cell Biochem Biophys, 70, 209, 10.1007/s12013-014-9884-9 Kapila, 1995, Measured context-sensitive half-times of remifentanil and alfentanil, Anesthesiology, 83, 968, 10.1097/00000542-199511000-00009 Michelsen, 1996, The pharmacokinetics of remifentanil, J Clin Anesth, 8, 679, 10.1016/S0952-8180(96)00179-1 Bürkle, 1996, Remifentanil: a novel, short-acting, mu-opioid, Anesth Analg, 83, 646, 10.1213/00000539-199609000-00038 Hall, 2000, Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation, Br J Anaesth, 84, 100, 10.1093/oxfordjournals.bja.a013362 Sneyd, 2001, Remifentanil and fentanyl during anaesthesia for major abdominal and gynaecological surgery. An open, comparative study of safety and efficacy, Eur J Anaesthesiol, 18, 605, 10.1097/00003643-200109000-00008 Argoff, 2009, A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs, Mayo Clin Proc, 84, 602, 10.1016/S0025-6196(11)60749-0 Cabanero, 2009, Pronociceptive effects of remifentanil in a mouse model of postsurgical pain: effect of a second surgery, Anesthesiology, 111, 1334, 10.1097/ALN.0b013e3181bfab61 Sora, 1997, Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia, PNAS, 94, 1544, 10.1073/pnas.94.4.1544 Hamabe, 2008, Involvement of kappa opioid receptors in the inhibition of receptor desensitization and PKC activation induced by repeated morphine treatment, J Pharm Pharmacol, 60, 1183, 10.1211/jpp.60.9.0010 Gear, 2014, NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids, Neuroscience, 257, 139, 10.1016/j.neuroscience.2013.10.061